title: Changes in mouse brain metabolism following a convulsive dose of soman: a proton HRMAS NMR study.
abstract: Soman, an irreversible organophosphorus cholinesterase inhibitor, induces status epilepticus and, in sensitive brain areas, seizure-related brain damage (e.g. brain edema and neuronal loss). The brain metabolic disturbances associated with these events are ill known. In the present study, we thus evaluated these changes in a murine model of soman-induced status epilepticus up to 7 days after intoxication. Mice, protected by HI-6 and atropine methyl nitrate, were poisoned with soman (172 microg/kg) and then sacrificed at set time points, from 1 h to 7 days. Brain biopsies from the piriform cortex (Pir) and cerebellum (Cer) were analyzed by 1H HRMAS NMR spectroscopy. Spectra were then analyzed using both a supervised multivariate analysis and the QUEST procedure of jMRUI for the quantification of 17 metabolites. The multivariate analysis clearly showed the metabolic differences between a damaged structure (Pir) and a structure with less prominent changes (cerebellum) and helped to globally assess the time course of metabolic changes. Analysis of the individual metabolites showed that the major changes took place in the piriform cortex but that cerebellum was not change-free. The most prominent changes in the former were an early (1-4 h) increase in alanine and acetate, a delayed increase in lactate, glycerophosphocholine and glutamine as well as a delayed decrease in myo-inositol and N-acetylaspartate. A week after poisoning, some metabolic disturbances were still present. Further research will be necessary to clarify what could be the involvement of these metabolites in physiological processes and how they might become useful surrogate markers of brain damage and repair.
authors.affiliation: Unité de Biophysique Cellulaire et Moleculaire, Institut de Recherche Biomédicale des Armées, Centre de Recherches du Service Santé des Armées BP87, 38702 La Tronche Cedex, France.
authors.forename: F
authors.initials: F
authors.lastname: Fauvelle
authors.forename: F
authors.initials: F
authors.lastname: Dorandeu
authors.forename: P
authors.initials: P
authors.lastname: Carpentier
authors.forename: A
authors.initials: A
authors.lastname: Foquin
authors.forename: H
authors.initials: H
authors.lastname: Rabeson
authors.forename: D
authors.initials: D
authors.lastname: Graveron-Demilly
authors.forename: P
authors.initials: P
authors.lastname: Arvers
authors.forename: G
authors.initials: G
authors.lastname: Testylier
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D002800:Cholinesterase Inhibitors / Q000633:toxicity*; D004195:Disease Models, Animal; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D051379:Mice; D011522:Protons; D012999:Soman / Q000633:toxicity*; D013226:Status Epilepticus / Q000139:chemically induced / Q000473:pathology
chemical_list: D002800:Cholinesterase Inhibitors; D011522:Protons; D012999:Soman